On August 24th, 2001 a proposed class action was commenced against Bayer Inc. (“Bayer”) arising out of that company’s marketing of the cholesterol-lowering drug known alternatively as Baycol, Cervastatin or Lipobay (“Baycol”).
Counsel for the proposed class action were Branch MacMaster, Hanson Wirsig Matheos and Joseph M. Prodor.